Perosphere
Danbury
About Perosphere
Perosphere also identifies market opportunities where application of drug delivery technology to an already marketed drug can create a new patent-protected medical use or enhance safety, efficacy or ease of use. Perosphere recognizes the scientific and marketing opportunities afforded by its drug candidates and pursues clinical development using the U.S. FDA's 505(b)(2) regulatory pathway whenever possible. The 505(b)(2) pathway enables the expedited development of drug candidates that are based on drugs already demonstrated to be safe and effective. Perosphere's proprietary drug delivery technology is protected by over 30 issued and 10 pending patents.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $11.9M
- Last round: Series Unknown (Feb 2016)
- Website: perosphere.com
- Phone: +112038851111
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/perosphere-159308 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.